World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
30079
World Ranking
11341
National Ranking
444

Andrew Bottomley publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Andrew Bottomley sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 389 publications — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Andrew Bottomley D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Andrew Bottomley sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 92 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Andrew Bottomley is affiliated with the European Organisation for Research and Treatment of Cancer in the Netherlands. Their primary field of study is Medicine, with a substantial focus on Oncology, alongside significant work in Pulmonary and Respiratory Medicine, Economics and Econometrics, Genetics, and Public Health, Environmental and Occupational Health.

Themes prominently addressed in Bottomley's research include:

  • Cancer survivorship and care
  • Health Systems, Economic Evaluations, Quality of Life
  • Glioma Diagnosis and Treatment
  • Palliative Care and End-of-Life Issues
  • Economic and Financial Impacts of Cancer
  • Brain Metastases and Treatment
  • Cancer-related cognitive impairment studies

Frequent coauthors contributing to a significant portion of Bottomley's publications are:

  • Corneel Coens
  • Galina Velikova
  • Jaap C. Reijneveld
  • Madeleine King
  • Mogens Grøenvold

Bottomley's research has been published often in the following venues:

  • European Journal of Cancer
  • The Lancet Oncology
  • Quality of Life Research
  • Neuro-Oncology
  • Current Opinion in Supportive and Palliative Care

Notable recent publications include:

  • International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium (2020), The Lancet Oncology
  • Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types (2023), European Journal of Cancer
  • SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials (2021), BMJ Open
  • An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45 (2020), Annals of Oncology
  • Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer (2022), European Journal of Cancer

Best Publications

  • EORTC QLQ-C30 Scoring Manual

    Peter Fayers;N. K. Aaronson;N. K. Aaronson;K. Bjordal;K. Bjordal;K. Bjordal;M. Groenvold

  • Quality of life research within the EORTC the EORTC QLQ-C30

    P Fayers;P Fayers;A Bottomley

  • Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada

    Jan P. van Meerbeeck;Rabab Gaafar;Christian Manegold;Rob J. Van Klaveren

  • Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.

    Melanie Calvert;Derek Kyte;Rebecca Mercieca-Bebber;Anita Slade

  • A European Organisation for Research and Treatment of Cancer Phase III Trial of Adjuvant Whole-Brain Radiotherapy Versus Observation in Patients With One to Three Brain Metastases From Solid Tumors After Surgical Resection or Radiosurgery: Quality-of-Life Results

    Riccardo Soffietti;Martin Kocher;Ufuk M. Abacioglu;Salvador Villa

  • The development of the EORTC QLQ-C15-PAL: A shortened questionnaire for cancer patients in palliative care

    Mogens Groenvold;Mogens Groenvold;Morten Aa. Petersen;Neil K. Aaronson;Juan I. Arraras

  • The Prognostic Significance of Patient-Reported Outcomes in Cancer Clinical Trials

    Carolyn C. Gotay;Crissy T. Kawamoto;Andrew Bottomley;Fabio Efficace

  • Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials

    Chantal Quinten;Corneel Coens;Murielle E. L. Mauer;Sylvie Comte

  • The cancer patient and quality of life.

    Andrew Bottomley

  • An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancer

    George van Andel;Andrew Bottomley;Sophie D. Fosså;Fabio Efficace

  • Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer.

    J.M Blazeby;T Conroy;E Hammerlid;P Fayers

  • EORTC QLQ–C30 Reference Values Manual

    Neil William Scott;Peter Fayers;Neil K Aaronson;Andrew Bottomley

  • Health-related quality of life in patients with glioblastoma: a randomised controlled trial

    Martin J B Taphoorn;Roger Stupp;Corneel Coens;David Osoba

  • Beyond the Development of Health-Related Quality-of-Life (HRQOL) Measures: A Checklist for Evaluating HRQOL Outcomes in Cancer Clinical Trials--Does HRQOL Evaluation in Prostate Cancer Research Inform Clinical Decision Making?

    Fabio Efficace;Andrew Bottomley;David Osoba;Carolyn Gotay

  • An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients.

    Martin J.B. Taphoorn;Lily Claassens;Neil K. Aaronson;Corneel Coens

  • Translation procedures for standardised quality of life questionnaires: The European Organisation for Research and Treatment of Cancer (EORTC) approach

    Michael Koller;Neil K. Aaronson;Jane Blazeby;Andrew Bottomley

  • Prophylactic Cranial Irradiation in Extensive Disease Small-Cell Lung Cancer: Short-Term Health-Related Quality of Life and Patient Reported Symptoms--Results of an International Phase III Randomized Controlled Trial by the EORTC Radiation Oncology and Lung Cancer Groups

    Berend J. Slotman;Murielle E. Mauer;Andrew Bottomley;Corinne Faivre-Finn

  • EORTC Quality of Life Group translation procedure

    L Dewolf;M Koller;G Velikova;C Johnson

  • Initial phase II results with crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC): PROFILE 1005.

    L. Crino;D. Kim;G. J. Riely;P. A. Janne

  • Patient Self-Reports of Symptoms and Clinician Ratings as Predictors of Overall Cancer Survival

    Chantal Quinten;John Maringwa;Carolyn C. Gotay;Francesca Martinelli

Frequent Co-Authors

Neil K. Aaronson
Neil K. Aaronson Antoni van Leeuwenhoek Hospital
Madeleine King
Madeleine King University of Sydney
Mirjam A. G. Sprangers
Mirjam A. G. Sprangers University of Amsterdam
Peter Fayers
Peter Fayers University of Aberdeen
Edward Chow
Edward Chow Sunnybrook Health Science Centre
Joachim Weis
Joachim Weis RWTH Aachen University
Martin J. van den Bent
Martin J. van den Bent Erasmus University Rotterdam
Jane M Blazeby
Jane M Blazeby University of Bristol
Wolfgang Wick
Wolfgang Wick German Cancer Research Center
David Osoba
David Osoba University of British Columbia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medical careers but seeking flexible study options, online nursing degrees offer excellent alternatives. These pathways allow students and working professionals to advance their education without relocating or giving up employment.

The cheap online fnp programs are ideal for those who want to become a Family Nurse Practitioner (FNP) with a lower tuition burden. Additionally, RNs aiming to complete their bachelor’s degree can benefit from the cheapest rn to bsn online options, providing an affordable route to career growth.

For professionals pursuing academia and research, online nursing phd programs offer flexible pathways to the highest level of nursing education. Meanwhile, the cheapest online bsn programs make it easier for registered nurses to earn their BSN credentials at minimal cost.

Exploring these online degree programs can lead to rewarding careers in patient care, healthcare leadership, teaching, and research, all while making education more accessible and affordable.

Best Scientists Citing Andrew Bottomley

Trending Scientists

Recently Published Articles